GB9901808D0 - Drugs for treatment of psychiatric and brain disorders - Google Patents

Drugs for treatment of psychiatric and brain disorders

Info

Publication number
GB9901808D0
GB9901808D0 GBGB9901808.7A GB9901808A GB9901808D0 GB 9901808 D0 GB9901808 D0 GB 9901808D0 GB 9901808 A GB9901808 A GB 9901808A GB 9901808 D0 GB9901808 D0 GB 9901808D0
Authority
GB
United Kingdom
Prior art keywords
psychiatric
drugs
treatment
brain disorders
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9901808.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scarista Ltd
Original Assignee
Scarista Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scarista Ltd filed Critical Scarista Ltd
Priority to GBGB9901808.7A priority Critical patent/GB9901808D0/en
Publication of GB9901808D0 publication Critical patent/GB9901808D0/en
Priority to AU30638/00A priority patent/AU3063800A/en
Priority to PCT/GB2000/000137 priority patent/WO2000044360A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
GBGB9901808.7A 1999-01-27 1999-01-27 Drugs for treatment of psychiatric and brain disorders Ceased GB9901808D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9901808.7A GB9901808D0 (en) 1999-01-27 1999-01-27 Drugs for treatment of psychiatric and brain disorders
AU30638/00A AU3063800A (en) 1999-01-27 2000-01-20 Drugs for treatment of psychiatric and brain disorders
PCT/GB2000/000137 WO2000044360A2 (en) 1999-01-27 2000-01-20 Drugs for treatment of psychiatric and brain disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9901808.7A GB9901808D0 (en) 1999-01-27 1999-01-27 Drugs for treatment of psychiatric and brain disorders

Publications (1)

Publication Number Publication Date
GB9901808D0 true GB9901808D0 (en) 1999-03-17

Family

ID=10846602

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9901808.7A Ceased GB9901808D0 (en) 1999-01-27 1999-01-27 Drugs for treatment of psychiatric and brain disorders

Country Status (3)

Country Link
AU (1) AU3063800A (en)
GB (1) GB9901808D0 (en)
WO (1) WO2000044360A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8729124B2 (en) 2002-03-05 2014-05-20 Pronova Biopharma Norge As Use of EPA and DHA in secondary prevention
US20060217303A1 (en) * 2005-03-25 2006-09-28 Wisconsin Alumni Research Foundation Compounds and Methods for Treating Seizure Disorders

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8319073D0 (en) * 1983-07-14 1983-08-17 Efamol Ltd Fatty acid compositions
US4678808A (en) * 1985-10-15 1987-07-07 Baxter Travenol Laboratories, Inc. Rapid acting intravenous emulsions of omega-3 fatty acid esters
GB8714772D0 (en) * 1987-06-24 1987-07-29 Efamol Ltd Essential fatty acid compositions
GB8813766D0 (en) * 1988-06-10 1988-07-13 Efamol Holdings Essential fatty acid compositions
US5658767A (en) * 1991-01-24 1997-08-19 Martek Corporation Arachidonic acid and methods for the production and use thereof
JPH06237734A (en) * 1991-11-06 1994-08-30 Sanwa Kagaku Kenkyusho Co Ltd Food composition for hypofunctional disease
GB9224809D0 (en) * 1992-11-26 1993-01-13 Scotia Holdings Plc Schizophrenia
AU673700B2 (en) * 1993-01-27 1996-11-21 Scotia Holdings Plc Triglycerides
JPH08143454A (en) * 1994-11-17 1996-06-04 Kanagawa Kagaku Kenkyusho:Kk Nerve growth factor production enhancer
GB9506837D0 (en) * 1995-04-03 1995-05-24 Scotia Holdings Plc Triglycerides
AU6252196A (en) * 1995-06-07 1996-12-30 Martek Biosciences Corporation Methods for controlling highly unsaturated fatty acid content in various tissues
GB9515160D0 (en) * 1995-07-24 1995-09-20 Scotia Holdings Plc Diagnostic test
AU2738497A (en) * 1996-04-24 1997-11-12 Brigham And Women's Hospital Omega-3 fatty acids and omega-3 phosphatidylcholine in the treatment of bipolar disorder
KR100657642B1 (en) * 1996-10-11 2006-12-19 스카리스타 리미티드 Oil comprising eicosapentaenoic acid and/or stearidonic acid
AU7222598A (en) * 1997-04-29 1998-11-24 Scotia Holdings Plc Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants

Also Published As

Publication number Publication date
WO2000044360A2 (en) 2000-08-03
WO2000044360A3 (en) 2000-11-30
AU3063800A (en) 2000-08-18

Similar Documents

Publication Publication Date Title
HUP0400914A3 (en) Methods of treatment of mitochondrial disorders
AU2001236904A1 (en) Deep brain stimulation system for the treatment of parkinson's disease or other disorders
AU6462500A (en) Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
HUP0100815A3 (en) Pharmaceutical for treatment of neurological and neuropsychiatric disorders
IL133800A0 (en) Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
AU8119001A (en) Hybrid neuroprosthesis for the treatment of brain disorders
PL339425A1 (en) Treatment of behavioural disorders
AU8187701A (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
IL127943A0 (en) Pharmaceutical and cosmetic composition for the treatment of skin disorders
IL141263A0 (en) Methods for treatment of neurological disorders
PL350679A1 (en) Derivatives of 1-arenosulphonyl-2-arylpyrolydine and piperidine for treating central nervous system disorders
AU6910600A (en) Methods for the treatment of mental disorders
GB9908175D0 (en) Method of treating neurological disorders
AU2001271887A1 (en) Methods for diagnosis and treatment of psychiatric disorders
HK1051485A1 (en) Treatment of hyperproliferative disorders
GB9926968D0 (en) Treatment of neurological disorders
HUP0102436A3 (en) Use of reboxetin for preparation of medicament for nervous disorders
AU2003278084A1 (en) Benzo(d)azepine derivatives for the treatment of neurological and psychiatric disorders
GB9901808D0 (en) Drugs for treatment of psychiatric and brain disorders
IL131347A0 (en) Treatment of skin disorders
IL152782A0 (en) S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders
AU2080201A (en) Treatment of addiction disorders
AU2566201A (en) Compounds and methods for the treatment of pain
IL143181A0 (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)